Precigen Future Growth
Future criteria checks 5/6
Precigen is forecast to grow earnings and revenue by 64.1% and 58.2% per annum respectively while EPS is expected to grow by 65.4% per annum.
Key information
64.1%
Earnings growth rate
65.4%
EPS growth rate
Biotechs earnings growth | 39.7% |
Revenue growth rate | 58.2% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 224 | 71 | 10 | 48 | 2 |
12/31/2025 | 22 | -72 | -72 | -57 | 5 |
12/31/2024 | 4 | -125 | -95 | -91 | 5 |
6/30/2024 | 4 | -135 | -78 | -70 | N/A |
3/31/2024 | 5 | -97 | -68 | -63 | N/A |
12/31/2023 | 6 | -96 | -68 | -67 | N/A |
9/30/2023 | 7 | -85 | -67 | -67 | N/A |
6/30/2023 | 22 | -73 | -75 | -73 | N/A |
3/31/2023 | 23 | -79 | -68 | -65 | N/A |
12/31/2022 | 27 | -80 | -70 | -65 | N/A |
9/30/2022 | 29 | -84 | -72 | -64 | N/A |
6/30/2022 | 15 | -103 | -66 | -57 | N/A |
3/31/2022 | 16 | -108 | -66 | -58 | N/A |
12/31/2021 | 14 | -111 | -63 | -56 | N/A |
9/30/2021 | 30 | -124 | -64 | -58 | N/A |
6/30/2021 | 50 | -125 | -64 | -60 | N/A |
3/31/2021 | 77 | -110 | -71 | -66 | N/A |
12/31/2020 | 32 | -104 | -85 | -77 | N/A |
9/30/2020 | 101 | -100 | -103 | -93 | N/A |
6/30/2020 | 96 | -122 | -118 | -101 | N/A |
3/31/2020 | 98 | -138 | -150 | -120 | N/A |
12/31/2019 | 91 | -169 | -174 | -136 | N/A |
9/30/2019 | 108 | -373 | -186 | -141 | N/A |
6/30/2019 | 122 | -381 | -188 | -143 | N/A |
3/31/2019 | 134 | -414 | -180 | -138 | N/A |
12/31/2018 | 151 | -375 | -166 | -124 | N/A |
9/30/2018 | 194 | -196 | -165 | -121 | N/A |
6/30/2018 | 208 | -179 | -164 | -114 | N/A |
3/31/2018 | 217 | -132 | N/A | -109 | N/A |
12/31/2017 | 219 | -71 | N/A | -104 | N/A |
9/30/2017 | 200 | -134 | N/A | -94 | N/A |
6/30/2017 | 203 | -123 | N/A | -88 | N/A |
3/31/2017 | 201 | -154 | N/A | -77 | N/A |
12/31/2016 | 191 | -187 | N/A | -49 | N/A |
9/30/2016 | 186 | -175 | N/A | -19 | N/A |
6/30/2016 | 191 | -184 | N/A | 49 | N/A |
3/31/2016 | 183 | -176 | N/A | 45 | N/A |
12/31/2015 | 174 | -84 | N/A | 36 | N/A |
9/30/2015 | 163 | -33 | N/A | 14 | N/A |
6/30/2015 | 131 | -47 | N/A | -45 | N/A |
3/31/2015 | 98 | -59 | N/A | -42 | N/A |
12/31/2014 | 72 | -82 | N/A | -20 | N/A |
9/30/2014 | 48 | -113 | N/A | -21 | N/A |
6/30/2014 | 33 | -52 | N/A | -30 | N/A |
3/31/2014 | 28 | -11 | N/A | -30 | N/A |
12/31/2013 | 24 | -57 | N/A | -54 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: I5X is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: I5X is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: I5X is expected to become profitable in the next 3 years.
Revenue vs Market: I5X's revenue (58.2% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: I5X's revenue (58.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if I5X's Return on Equity is forecast to be high in 3 years time